GT Biopharma Inc (NAS:GTBP)
$ 2.8825 -0.0075 (-0.26%) Market Cap: 6.22 Mil Enterprise Value: -3.54 Mil PE Ratio: 0 PB Ratio: 0.75 GF Score: 33/100

Q2 2021 GT Biopharma Inc Earnings Call Transcript

Aug 13, 2021 / 12:30PM GMT
Release Date Price: $300.3 (-7.40%)
Operator

Greetings, and welcome to the GT Biopharma second-quarter 2021 conference call. (Operator Instructions) At this time, I'd like to turn the conference call over to David Castaneda, Investor Relations for the company. Thank you. You may proceed.

David Castaneda
GT Biopharma, Inc. - IR

Thank you, operator. Good morning, everyone, and welcome to GT Biopharma second-quarter 2021 conference call. Earlier this morning, we issued a press release summarizing the company's second-quarter 2021 corporate updates that management will discuss on the call today. You can access the press release by going to the News & Media section and then the press releases page on our website at gtbiopharma.com.

GT Biopharma's following presentation and ensuing question-and-answer session will include statements that are or may be deemed forward-looking statements. In some cases, you can identify forward-looking statements by terminology, including, anticipates, believes, can, continue, could, estimates, expects, intends, may, plans, potential, predicts, should, will, would or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot